
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses the major benefits of introducing new technology to community pharmacy.
Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses the major benefits of introducing new technology to community pharmacy.
This video was recorded at the 2015 NACDS Total Store Expo.






